Direct evidences for mGluR1-driven melanoma formation and progression were provided in the same year by Ohtani and coworkers who showed that mGluR1 conditionally expressed in melanocyte-induced pigmented lesions at the first stage, followed by appearance of melanoma tumors 52 weeks after transgene activation. This evidence concerns the gene GRM1 and melanoma.